Virtual Reality Intervention for Patients Undergoing BMT
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 80 people, planned
- Started
- 20 Dec 2022
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- BMT-VR
- Record updated
- 15 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adult patients (age > 18 years) with hematologic malignancy admitted for autologous or allogeneic BMT
- Ability to comprehend, read, and respond to questions in English as BMT-VR is only available in English
Who cannot take part
- Patients undergoing BMT for benign hematologic conditions
- Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures
- Patients undergoing outpatient BMT
Where in United States
- Massachusetts General Hospital Cancer CenterBoston, United States
About the trial
What the trial wants to find out
The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigned into one of the study groups: the virtual reality psychosocial intervention (BMT-VR) + usual care versus usual care alone.
Read full original descriptionShow less
The BMT-VR intervention has several components:
1. Psychoeducation to enhance preparedness, manage expectations, and mobilize social supports. 2. Psychosocial skill building to promote effective coping and facilitate acceptance while living with uncertainty of treatment outcomes. 3. Self-care to promote effective coping and enhance patient's sense of control as they transition from inpatient to outpatient care
The 2 groups in the trial
- BMT-VR GroupTreatment being tested
* Participants will complete the BMT-VR intervention during their BMT hospitalization, which contains six sections. * Participants will receive usual transplant care by their BMT team * Participants will complete study questionnaires to assess their quality of life and psychological outcomes * 10-20 participants will complete exit interviews to ascertain more feedback on the BMT-VR intervention.
Treatment: BMT-VR
- Usual careNo study treatment, for comparison
* Participants will receive usual transplant care by their BMT team * Participants will complete study questionnaires to assess their quality of life and psychological outcomes
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Randomized Controlled Trial of a Virtual Reality Psychosocial Intervention to Promote Coping for Patients Undergoing Bone Marrow Transplantation (BMT-VR)
- Record updated
- 15 May 2026